GLP-1 Agonists Through a Functional Lens: Pharmacotherapy, Physiology, and Patient Support

This activity aligns with clinicians’ scope by supporting appropriate assessment, testing decisions, patient counseling, and referral for suspected SIBO within outpatient and primary care practice

Target Audience

This activity is designed for an audience of Physicians, PAs, Pharmacists, and Nurses.

Learning Objectives

  • Describe the physiology of GLP-1 signaling and its role in appetite regulation, glycemic control, and cardiometabolic health.
  • Identify evidence-based lifestyle, dietary, and nutraceutical strategies shown to naturally support endogenous GLP-1 activity.
  • Compare currently available GLP-1 receptor agonists, including mechanisms of action, approved indications, and key clinical considerations.
  • Apply integrative nutrition and lifestyle strategies to support patients using GLP-1 medications, with a focus on GI tolerance, lean mass preservation, and long-term metabolic health

Commercial Support
There is no commercial support for this activity.

 

Course summary
Available credit: 
  • 1.00 AANP
  • 1.00 AAPA Category 1 CME
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 CDR
Course opens: 
02/20/2026
Course expires: 
02/20/2027
Cost:
$0.00
Rating: 
0

Melody Hartzler, PharmD (faculty)

Advisor

Designs for Health Advisory Board

Dorothy Caputo, MA, BSN, RN - President, AKH Inc., Advancing Knowledge in Healthcare

N/A

Nothing to disclose

Becca Lakofsky , BSN (planner/reviewer)

N/A

Nothing to disclose

AKH Inc Staff and Planners

N/A

Nothing to disclose

Revelar Health, LLC Staff and Planners

N/A

Nothing to disclose

All of the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Revelar Health, LLC.  AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

 

 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

 

 

Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.0 contact hours.

 

Nursing
Credit being awarded: 1.0 ANCC contact hours

 

 

 

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 02/20/2027 PAs should only claim credit commensurate with the extent of their participation.

 

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and JP.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.0 contact hour(s)

 

 

Dietitians


 

 

Available Credit

  • 1.00 AANP
  • 1.00 AAPA Category 1 CME
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 CDR

Price

Cost:
$0.00
Please login or register to take this course.